Cyclodextrin-based pharmaceutics: Past, present and future

被引:1633
作者
Davis, ME [1 ]
Brewster, ME
机构
[1] CALTECH, Pasadena, CA 91125 USA
[2] Johnson & Johnson Pharmaceut Res & Dev, B-2340 Beerse, Belgium
关键词
D O I
10.1038/nrd1576
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Cyclodextrins are cyclic oligomers of glucose that can form water-soluble inclusion complexes with small molecules and portions of large compounds. These biocompatible, cyclic oligosaccharides do not elicit immune responses and have low toxicities in animals and humans. Cyclodextrins are used in pharmaceutical applications for numerous purposes, including improving the bioavailability of drugs. Current cyclodextrin-based therapeutics are described and possible future applications discussed. Cyclodextrin-containing polymers are reviewed and their use in drug delivery presented. Of specific interest is the use of cyclodextrin-containing polymers to provide unique capabilities for the delivery of nucleic acids.
引用
收藏
页码:1023 / 1035
页数:13
相关论文
共 159 条
  • [91] PHARMACOKINETICS OF OXICAM NONSTEROIDAL ANTIINFLAMMATORY AGENTS
    OLKKOLA, KT
    BRUNETTO, AV
    MATTILA, MJ
    [J]. CLINICAL PHARMACOKINETICS, 1994, 26 (02) : 107 - 120
  • [92] PAGINGTON JS, 1987, CHEM BRIT, V23, P455
  • [93] Dose-ranging studies of a novel intranasal estrogen replacement therapy
    Panay, N
    Toth, K
    Pelissier, C
    Studd, J
    [J]. MATURITAS, 2001, 38 : S15 - S22
  • [94] COMPARISON OF FECAL BLOOD-LOSS, UPPER GASTROINTESTINAL MUCOSAL INTEGRITY AND SYMPTOMS AFTER PIROXICAM BETA-CYCLODEXTRIN, PIROXICAM AND PLACEBO ADMINISTRATION
    PATOIA, L
    CLAUSI, G
    FARRONI, F
    ALBERTI, P
    FUGIANI, P
    BUFALINO, L
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 36 (06) : 599 - 604
  • [95] Characterization of the Interaction of 2-hydroxypropyl-β-cyclodextrin with itraconazole at pH 2, 4, and 7
    Peeters, J
    Neeskens, P
    Tollenaere, JP
    Van Remoortere, P
    Brewster, ME
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (06) : 1414 - 1422
  • [96] Clinical evaluation, dose-finding and acceptability of AERODIOL®, the pulsed estrogen therapy for treatment of climacteric symptoms
    Pelissier, C
    de Kervasdoue, A
    Chuong, VT
    Maugis, EL
    de Mouillac, FV
    Breil, MH
    Moniot, G
    Zeitoun-Lepvrier, G
    Robin, M
    Rime, B
    [J]. MATURITAS, 2001, 37 (03) : 181 - 189
  • [97] Pierard G E, 2000, Expert Opin Pharmacother, V1, P287, DOI 10.1517/14656566.1.2.287
  • [98] Structural effects of carbohydrate-containing polycations on gene delivery. 3. Cyclodextrin type and functionalization
    Popielarski, SR
    Mishra, S
    Davis, ME
    [J]. BIOCONJUGATE CHEMISTRY, 2003, 14 (03) : 672 - 678
  • [99] PHARMACEUTICAL INNOVATION BY THE 7 UK-OWNED PHARMACEUTICAL COMPANIES (1964-1985)
    PRENTIS, RA
    LIS, Y
    WALKER, SR
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (03) : 387 - 396
  • [100] Cyclodextrin-modified polyethylenimine polymers for gene delivery
    Pun, SH
    Bellocq, NC
    Liu, AJ
    Jensen, G
    Machemer, T
    Quijano, E
    Schluep, T
    Wen, SF
    Engler, H
    Heidel, J
    Davis, ME
    [J]. BIOCONJUGATE CHEMISTRY, 2004, 15 (04) : 831 - 840